Citadel Advisors’s Red Violet RDVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,500
Closed -$56.4K 14638
2025
Q1
$56.4K Sell
1,500
-1,000
-40% -$37.7K ﹤0.01% 12179
2024
Q4
$90.5K Sell
2,500
-1,200
-32% -$40K ﹤0.01% 11624
2024
Q3
$105K Buy
3,700
+500
+16% +$13.6K ﹤0.01% 11048
2024
Q2
$81.3K Sell
3,200
-600
-16% -$12.1K ﹤0.01% 11190
2024
Q1
$74.3K Buy
3,800
+400
+12% +$7.33K ﹤0.01% 11746
2023
Q4
$67.9K Sell
3,400
-3,400
-50% -$67.8K ﹤0.01% 11421
2023
Q3
$136K Buy
6,800
+1,400
+26% +$29K ﹤0.01% 10505
2023
Q2
$111K Buy
+5,400
New +$101K ﹤0.01% 10771

Other funds holding RDVT

Citadel Advisors's RDVT Position: Q1 2026 in Review

Citadel Advisors increased its Red Violet (RDVT) stake by 73% in Q1 2026, buying an estimated $1.01M and bringing the position to 54,418 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #6191.

Citadel Advisors first reported a position in RDVT in Q1 2018 and has held it in 19 quarters since. The position peaked at $3.62M in Q2 2025. 161 funds tracked by Wall St. Rank hold RDVT as of Q1 2026.

  • Citadel Advisors held 54,418 shares of Red Violet worth $1.88M as of Q1 2026.
  • Citadel Advisors bought 22,947 Red Violet shares in Q1 2026, an estimated $1.01M.
  • Red Violet made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6191 holding.
  • Citadel Advisors first reported a position in Red Violet in Q1 2018 and has held it in 19 quarters since.
  • Citadel Advisors's Red Violet position peaked at $3.62M in Q2 2025.
  • 161 funds tracked by Wall St. Rank held Red Violet as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.